KR20190009303A - 건 퇴행의 치료에 사용하기 위한 조성물 - Google Patents

건 퇴행의 치료에 사용하기 위한 조성물 Download PDF

Info

Publication number
KR20190009303A
KR20190009303A KR1020187033872A KR20187033872A KR20190009303A KR 20190009303 A KR20190009303 A KR 20190009303A KR 1020187033872 A KR1020187033872 A KR 1020187033872A KR 20187033872 A KR20187033872 A KR 20187033872A KR 20190009303 A KR20190009303 A KR 20190009303A
Authority
KR
South Korea
Prior art keywords
composition
carbohydrate
hyaluronic acid
injection
group
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
KR1020187033872A
Other languages
English (en)
Korean (ko)
Inventor
콜린 디. 화이트
에드워드 에스. 안
세코니 다우다 노엘
Original Assignee
아니카 테라퓨틱스, 인코포레이티드
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 아니카 테라퓨틱스, 인코포레이티드 filed Critical 아니카 테라퓨틱스, 인코포레이티드
Publication of KR20190009303A publication Critical patent/KR20190009303A/ko
Ceased legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/14—Macromolecular materials
    • A61L27/20—Polysaccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/39—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin, cold insoluble globulin [CIG]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/38—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells
    • A61L27/3839—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells characterised by the site of application in the body
    • A61L27/3843—Connective tissue
    • A61L27/386—Ligaments, tendons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/04—Drugs for skeletal disorders for non-specific disorders of the connective tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2400/00—Materials characterised by their function or physical properties
    • A61L2400/06—Flowable or injectable implant compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2430/00—Materials or treatment for tissue regeneration
    • A61L2430/10—Materials or treatment for tissue regeneration for reconstruction of tendons or ligaments

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Dermatology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Transplantation (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Cell Biology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rehabilitation Therapy (AREA)
  • Rheumatology (AREA)
  • Vascular Medicine (AREA)
  • Botany (AREA)
  • Physical Education & Sports Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Materials For Medical Uses (AREA)
  • Peptides Or Proteins (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Details Of Rigid Or Semi-Rigid Containers (AREA)
  • Closures For Containers (AREA)
KR1020187033872A 2016-04-27 2017-04-26 건 퇴행의 치료에 사용하기 위한 조성물 Ceased KR20190009303A (ko)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201662328396P 2016-04-27 2016-04-27
US62/328,396 2016-04-27
US201662367377P 2016-07-27 2016-07-27
US62/367,377 2016-07-27
PCT/US2017/029635 WO2017189723A1 (en) 2016-04-27 2017-04-26 Compositions for use in treating tendon degeneration

Publications (1)

Publication Number Publication Date
KR20190009303A true KR20190009303A (ko) 2019-01-28

Family

ID=58709560

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020187033872A Ceased KR20190009303A (ko) 2016-04-27 2017-04-26 건 퇴행의 치료에 사용하기 위한 조성물

Country Status (15)

Country Link
US (1) US10441677B2 (https=)
EP (1) EP3448394B1 (https=)
JP (1) JP6826657B2 (https=)
KR (1) KR20190009303A (https=)
CN (1) CN109562124A (https=)
AU (1) AU2017257956B2 (https=)
CA (1) CA3021764C (https=)
IL (1) IL262507B (https=)
MX (1) MX375382B (https=)
NZ (1) NZ747413A (https=)
RU (1) RU2018141386A (https=)
SG (2) SG10201913342UA (https=)
TW (2) TWI755392B (https=)
WO (1) WO2017189723A1 (https=)
ZA (1) ZA201807136B (https=)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20240103830A (ko) * 2022-12-27 2024-07-04 차의과학대학교 산학협력단 비타민 d를 포함하는 건병증 또는 근육손상 치료용 히알루론산 하이드로겔계 약물 전달 시스템 및 이의 제조방법

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2018399962B2 (en) 2018-01-02 2024-11-14 Cartiheal (2009) Ltd. Implantation tool and protocol for optimized solid substrates promoting cell and tissue growth
JP2024006681A (ja) * 2022-07-04 2024-01-17 学校法人近畿大学 生体材料
WO2025096427A1 (en) * 2023-10-29 2025-05-08 Brown David Donaldson Methods for treating lower back pain with hyaluronic acid

Family Cites Families (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2946819A (en) 1958-04-14 1960-07-26 Gen Aniline & Film Corp Process of producing carbodimides
DE1156401B (de) 1960-05-24 1963-10-31 Bayer Ag Verfahren zur Herstellung von Carbodiimiden
DE1149712B (de) 1961-11-14 1963-06-06 Bayer Ag Verfahren zur Herstellung von Carbodiimiden
US3644456A (en) 1964-08-12 1972-02-22 Upjohn Co Di((isocyanatobenzyl)-phenyl) carbodiimides and preparation of organic carbodiimides
US3972933A (en) 1974-05-28 1976-08-03 Monsanto Company Preparation of carbodiimides from ureas by dehydration
GB1476088A (en) 1975-04-03 1977-06-10 Ici Ltd Carbodiimides
DE2556760A1 (de) 1975-12-17 1977-06-30 Hoechst Ag Verfahren zur herstellung von carbodiimiden
GB1584153A (en) 1976-09-22 1981-02-04 Ici Ltd Carbodimides
US4066629A (en) 1976-10-28 1978-01-03 Celanese Corporation Process for preparing carbodiimides utilizing a phosphonium salt catalyst
US4098973A (en) 1977-01-31 1978-07-04 The Upjohn Company Compounds and process
US4851521A (en) 1985-07-08 1989-07-25 Fidia, S.P.A. Esters of hyaluronic acid
IT1219587B (it) 1988-05-13 1990-05-18 Fidia Farmaceutici Polisaccaridi carbossiilici autoreticolati
US5356883A (en) 1989-08-01 1994-10-18 Research Foundation Of State University Of N.Y. Water-insoluble derivatives of hyaluronic acid and their methods of preparation and use
ITPD940054A1 (it) 1994-03-23 1995-09-23 Fidia Advanced Biopolymers Srl Polisaccaridi solfatati
DE69809892T2 (de) 1997-04-04 2003-08-28 Fidia Advanced Biopolymers S.R.L., Brindisi N-sulfatierte hyaluronsäureverbindungen, ihre derivate und verfahren zu ihrer herstellung
ITPD980169A1 (it) 1998-07-06 2000-01-06 Fidia Advanced Biopolymers Srl Ammidi dell'acido ialuronico e dei suoi derivati e processo per la loro preparazione.
ATE243049T1 (de) 1999-12-09 2003-07-15 Biosyntech Canada Inc Mineral-polymer hybrid-zusammensetzung
ATE392907T1 (de) 2000-07-28 2008-05-15 Anika Therapeutics Inc Bioabsorbierbare kompositmaterialien aus derivatisierter hyaluronsäure
IT1317359B1 (it) 2000-08-31 2003-06-16 Fidia Advanced Biopolymers Srl Polisaccaridi percarbossilati, quali l'acido ialuronico, processo perla loro preparazione e loro impiego in campo farmaceutico e
IT1317358B1 (it) 2000-08-31 2003-06-16 Fidia Advanced Biopolymers Srl Derivati cross-linkati dell'acido ialuronico.
ATE312076T1 (de) 2001-02-22 2005-12-15 Anika Therapeutics Inc Thiol-modifizierte hyaluronan-derivate
US20060272221A1 (en) 2001-11-29 2006-12-07 Treibacher Schleifmittel Gmbh Al2O3 and ZrO2 based abrasive grain, method for the production and use thereof
WO2003072157A1 (en) 2002-02-21 2003-09-04 Encelle, Inc. Immobilized bioactive hydrogel matrices as surface coatings
ITPD20020064A1 (it) 2002-03-12 2003-09-12 Fidia Advanced Biopolymers Srl Derivati esterei dell'acido ialuronico per la preparazione di idrogelda utilizzare in campo biomedico, sanitario e chirurgico e come sistem
ES2260616T3 (es) 2002-06-19 2006-11-01 Dr.H.C. Robert Mathys Stiftung Cemento hidraulico con base de fosfato de calcio destinado a uso quirurgico.
US8455458B2 (en) * 2002-10-16 2013-06-04 Arthrodynamic Technologies, Animal Health Division, Inc. Composition and method for treating connective tissue damage
DE10257554B4 (de) 2002-12-10 2008-04-10 Treibacher Schleifmittel Gmbh Schleifkörner mit einer Ummantelung aus einem wässrigen Bindemittel und einer komplexen feinkörnigen Oxidverbindung, Verfahren zur Behandlung derartiger Schleifkörner sowie ihre Verwendung für kunstharzgebundene Schleifmittel
EP1677806B1 (en) 2003-10-09 2008-11-19 Robert John Petrella Methods for treating acute and overuse sprain and strain using hyaluronic acid
US8124120B2 (en) 2003-12-22 2012-02-28 Anika Therapeutics, Inc. Crosslinked hyaluronic acid compositions for tissue augmentation
CA2633957A1 (en) 2005-12-14 2007-06-21 Anika Therapeutics, Inc. Treatment of arthritis and other musculoskeletal disorders with crosslinked hyaluronic acid
EP1891984A1 (en) 2006-08-24 2008-02-27 Graftys Macroporous and highly resorbable apatitic calcium-phosphate cement
IT1393419B1 (it) 2009-03-19 2012-04-20 Medivis S R L Composizioni oftalmiche a base di acidi grassi polinsaturi omega-3 e omega-6.
AU2010298484B2 (en) * 2009-09-23 2014-09-25 Glenpharma Ab Compositions and methods for inducing or enhancing connective tissue repair
CN102811622A (zh) * 2010-02-22 2012-12-05 生物模拟治疗公司 用于治疗腱病的血小板衍生生长因子组合物和方法
CA2838816C (en) 2011-06-09 2017-08-15 Zimmer Gmbh Instruments and devices for subchondral joint repair
EP2827914B1 (en) 2012-03-22 2019-05-08 TRB Chemedica International S.A. Method for repair of ligament or tendon
PT2900247T (pt) * 2012-09-26 2018-03-28 Bone Therapeutics Sa Composições contendo plasma tratado com dissolventes/detergentes e ácido hialurónico para serem utilizadas no tratamento de distúrbios músculo-esqueléticos
JP6721514B2 (ja) * 2014-02-20 2020-07-15 オルト リジェネレイティヴ テクノロジーズ インク．Ｏｒｔｈｏ Ｒｅｇｅｎｅｒａｔｉｖｅ Ｔｅｃｈｎｏｌｏｇｉｅｓ Ｉｎｃ． 多血小板血漿と混合し、組織修復のためのインプラントを形成するための凍結乾燥ポリマー組成物及び／又は治療用関節内注射のための組成物

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20240103830A (ko) * 2022-12-27 2024-07-04 차의과학대학교 산학협력단 비타민 d를 포함하는 건병증 또는 근육손상 치료용 히알루론산 하이드로겔계 약물 전달 시스템 및 이의 제조방법

Also Published As

Publication number Publication date
RU2018141386A3 (https=) 2020-05-27
EP3448394A1 (en) 2019-03-06
AU2017257956A1 (en) 2018-11-15
CN109562124A (zh) 2019-04-02
WO2017189723A1 (en) 2017-11-02
TW201739457A (zh) 2017-11-16
SG11201809197XA (en) 2018-11-29
ZA201807136B (en) 2021-05-26
MX375382B (es) 2025-03-06
RU2018141386A (ru) 2020-05-27
CA3021764A1 (en) 2017-11-02
WO2017189723A9 (en) 2018-06-28
AU2017257956B2 (en) 2019-11-07
EP3448394C0 (en) 2023-09-13
CA3021764C (en) 2021-01-19
TW202114712A (zh) 2021-04-16
SG10201913342UA (en) 2020-03-30
US10441677B2 (en) 2019-10-15
JP6826657B2 (ja) 2021-02-03
JP2019516784A (ja) 2019-06-20
EP3448394B1 (en) 2023-09-13
MX2018012964A (es) 2019-06-10
IL262507A (en) 2018-12-31
IL262507B (en) 2020-10-29
US20170326271A1 (en) 2017-11-16
NZ747413A (en) 2020-09-25
TWI755392B (zh) 2022-02-21

Similar Documents

Publication Publication Date Title
JP6113424B2 (ja) 安定化された多糖の処方のための組成物及び方法
JP4594866B2 (ja) 組織増大のための架橋ヒアルロン酸組成物
JP6359599B2 (ja) 関節を治療する組成物
KR20190009303A (ko) 건 퇴행의 치료에 사용하기 위한 조성물
US20200179419A1 (en) Method for the manufacture and use of a bionic hydrogel composition for medical applications
KR20210008101A (ko) 히알루론산과 줄기세포를 포함하는 연골손상 관련 질환 치료용 약학 조성물
JP5047814B2 (ja) 骨関節症におけるヒアルロン酸のアミド誘導体
RU2727241C2 (ru) Образование кости
JP2012521270A (ja) 軟骨修復
JP7191007B2 (ja) 線維軟骨組織損傷治療用組成物
JP2007507516A (ja) アミノ糖投与による哺乳動物の障害の治療及びアミノ糖の使用
HK40006859A (en) Compositions for use in treating tendon degeneration
HK40005732A (en) Compositions for use in treating tendon degeneration
HK40005732B (en) Compositions for use in treating tendon degeneration
JP6489487B2 (ja) テトラペプチド−３ ｇｅｋｇまたはペンタペプチド−３ ｇｅｋｇｆにより変形性関節症を治療するための新規用途
TWI698241B (zh) 用於治療缺血的肝素組合物
DK2318014T3 (en) New composition for the treatment of autoimmune diseases

Legal Events

Date Code Title Description
PA0105 International application

Patent event date: 20181122

Patent event code: PA01051R01D

Comment text: International Patent Application

AMND Amendment
PG1501 Laying open of application
A201 Request for examination
A302 Request for accelerated examination
AMND Amendment
PA0201 Request for examination

Patent event code: PA02012R01D

Patent event date: 20191030

Comment text: Request for Examination of Application

PA0302 Request for accelerated examination

Patent event date: 20191030

Patent event code: PA03022R01D

Comment text: Request for Accelerated Examination

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

Comment text: Notification of reason for refusal

Patent event date: 20200115

Patent event code: PE09021S01D

AMND Amendment
E601 Decision to refuse application
PE0601 Decision on rejection of patent

Patent event date: 20201125

Comment text: Decision to Refuse Application

Patent event code: PE06012S01D

Patent event date: 20200115

Comment text: Notification of reason for refusal

Patent event code: PE06011S01I

X091 Application refused [patent]
AMND Amendment
PX0901 Re-examination

Patent event code: PX09011S01I

Patent event date: 20201125

Comment text: Decision to Refuse Application

Patent event code: PX09012R01I

Patent event date: 20200831

Comment text: Amendment to Specification, etc.

Patent event code: PX09012R01I

Patent event date: 20191030

Comment text: Amendment to Specification, etc.

Patent event code: PX09012R01I

Patent event date: 20181204

Comment text: Amendment to Specification, etc.

PX0601 Decision of rejection after re-examination

Comment text: Decision to Refuse Application

Patent event code: PX06014S01D

Patent event date: 20210121

Comment text: Amendment to Specification, etc.

Patent event code: PX06012R01I

Patent event date: 20201224

Comment text: Decision to Refuse Application

Patent event code: PX06011S01I

Patent event date: 20201125

Comment text: Amendment to Specification, etc.

Patent event code: PX06012R01I

Patent event date: 20200831

Comment text: Notification of reason for refusal

Patent event code: PX06013S01I

Patent event date: 20200115

Comment text: Amendment to Specification, etc.

Patent event code: PX06012R01I

Patent event date: 20191030

Comment text: Amendment to Specification, etc.

Patent event code: PX06012R01I

Patent event date: 20181204

X601 Decision of rejection after re-examination
J201 Request for trial against refusal decision
PJ0201 Trial against decision of rejection

Patent event date: 20210323

Comment text: Request for Trial against Decision on Refusal

Patent event code: PJ02012R01D

Patent event date: 20210121

Comment text: Decision to Refuse Application

Patent event code: PJ02011S01I

Patent event date: 20201125

Comment text: Decision to Refuse Application

Patent event code: PJ02011S01I

Appeal kind category: Appeal against decision to decline refusal

Decision date: 20210809

Appeal identifier: 2021101000744

Request date: 20210323

J301 Trial decision

Free format text: TRIAL NUMBER: 2021101000744; TRIAL DECISION FOR APPEAL AGAINST DECISION TO DECLINE REFUSAL REQUESTED 20210323

Effective date: 20210809

PJ1301 Trial decision

Patent event code: PJ13011S01D

Patent event date: 20210809

Comment text: Trial Decision on Objection to Decision on Refusal

Appeal kind category: Appeal against decision to decline refusal

Request date: 20210323

Decision date: 20210809

Appeal identifier: 2021101000744